Title |
Spinal metastasis in thyroid cancer
|
---|---|
Published in |
Head & Neck Oncology, June 2012
|
DOI | 10.1186/1758-3284-4-39 |
Pubmed ID | |
Authors |
Sami Ramadan, Mohamed A Ugas, Richard J Berwick, Manisha Notay, Hyongyu Cho, Waseem Jerjes, Peter V Giannoudis |
Abstract |
Thyroid carcinoma generally responds well to treatment and spinal metastasis is an uncommon feature. Many studies have looked at the management of spinal metastasis and proposed treatments, plans and algorithms. These range from well-established methods to potentially novel alternatives including bisphosphonates and vascular endothelial growth factor (VEGF) therapy, amongst others.The purposes of this systematic review of the literature are twofold. Firstly we sought to analyse the proposed management options in the literature. Then, secondly, we endeavoured to make recommendations that might improve the prognosis of patients with spinal metastasis from thyroid carcinomas. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Greece | 1 | 33% |
United Kingdom | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 2% |
Netherlands | 1 | 2% |
Tunisia | 1 | 2% |
Unknown | 61 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 10 | 16% |
Other | 7 | 11% |
Student > Bachelor | 7 | 11% |
Student > Doctoral Student | 6 | 9% |
Student > Ph. D. Student | 5 | 8% |
Other | 19 | 30% |
Unknown | 10 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 41 | 64% |
Nursing and Health Professions | 4 | 6% |
Neuroscience | 2 | 3% |
Biochemistry, Genetics and Molecular Biology | 1 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Other | 4 | 6% |
Unknown | 11 | 17% |